This acquisition is expected to close in April 2019. Founded 2007, apceth is a pioneer in cell and gene therapy and has developed into a leading European contract
The post Hitachi Chemical to acquire apceth Biopharma appeared first on Pharmaceutical Business review.
Original Article: Hitachi Chemical to acquire apceth Biopharma